News Overview

Statement of Renovaro Inc

February 14, 2024

Statement of Renovaro Inc

We felt compelled to comment on the shorter Hindenburg’s opinion piece.

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces.

February 13, 2024

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces.

A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing.

AI Pioneer GEDiCube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

February 13, 2024

AI Pioneer GEDiCube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

“We believe this combination marks a significant milestone in the journey of personalized medicine,”

GEDiCube (Renovaro Cube) and Renovaro Biosciences Combine

September 29, 2023

GEDiCube (Renovaro Cube) and Renovaro Biosciences Combine

GEDiCube/Renovaro Cube and Renovaro Biosciences Sign a Definitive Agreement to Combine

Renovaro Cube joins NVIDIA Inception

August 30, 2023

Renovaro Cube joins NVIDIA Inception

Renovaro Cube joins NVIDIA Inception to advance unique platform for early cancer detection in clinical trials

Announcing Intent to Merge

August 9, 2023

Announcing Intent to Merge

AI Company GEDi Cube International and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

Transform cancer detection with data mining

July 31, 2023

Transform cancer detection with data mining

Renovaro Cube, an AI/ML platform, is delighted to announce the launch of its unique solution that combines differential molecular capabilities with multi-omic analysis to detect cancer at its earliest stage when it is in its most treatable state.